31
Views
2
CrossRef citations to date
0
Altmetric
Brief reports

Hot Topics in HIV and Hepatitis Coinfection: Noninvasive Diagnosis of Liver Disease, Liver Transplantation, and New Drugs for Treatment of Hepatitis Coinfection

Pages 110-115 | Published online: 06 Jan 2015

REFERENCES

  • Bedossa P, Dagere D, Parades V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003;38: 1449–1457.
  • Regev A, Berho M, Jeffers LJ, et al. Sampling error and intra-observer variation in liver biopsy in patients with chronic HCV-infection. Am J Gastroenterol. 2002;97:2614–2618.
  • Piccinio F, Sagnelli E, Pasquale G, et al. Complications fol-lowing percutaneous liver biopsy: a multicenter retrospec-tive study on 68,276 biopsies. J Hepatol. 1986;2:165–173
  • Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nation-wide survey for the group of epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology. 2000;32:477–481.
  • Sterling RK, Lissen, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibro-sis in patients with HIV/HCV coinfection. Hepatology. 2006;43:1317–1321.
  • Trang T, Petersen JR, Snyder N. Non-invasive markers of hepatic fibrosis in patients co-infected with HCV and HIV: comparison of the APRI and FIB-4 index. Clin Chim Acta. 2008;397:51–54.
  • Myer S, Benhamou Y, Imbert-Bismut F, et al. Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus coinfected patients. AIDS. 2003;17:721–725.
  • de Lédinghen V, Douvin C, Kettaneh A, et al. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr. 2006;41(2):175–179.
  • Panos G, Holmes P, Mandalia S, et al. Determination of transient elastography (TE) cut-off values for the detec-tion of significant hepatitis fibrosis through systemic review and meta-analysis and evaluation in HIV-positive individuals or the effect of body mass index (BMI), alcohol intake, smoking, gender, age on liver stiffness measure-ments. In: Program and abstracts from the 17th Interna-tional AIDS Conference; August 3–8, 2008; Mexico City. THAB 0203.
  • Pineda JA, Romero-Gomez M, Diaz-Garcia F, et al. HIV coinfection shortens the survival of patients with hepatitis C virus related decompensated cirrhosis. Hepatology. 2005;41:779–789.
  • Rockstroh JK, Spengler U. HIV and hepatitis C virus coin-fection. Lancet Infect Dis. 2004;4:437–444.
  • Miro JM, Laguno M, Moreno A, Rimola A, Hospital Clinic OLT in HIV Working Group. Management of end-stage liver disease (ESLD): what is the current role of orthotopic liver transplantation (OLT)? J Hepatol. 2006;44:S140–145.
  • Mindikoglu AL, Regev A, Magder LS. Impact of human immunodeficiency virus on survival after liver transplanta-tion: analysis of United Network for Organ Sharing database. Transplantation. 2008;85:359–368.
  • Vogel M, Voigt E, Schafer N, et al. Orthotopic liver trans-plantation in human immunodeficiency virus (HIV) positive patients: outcome of 7 patients from the Bonn cohort. Liver Transplant. 2005;11:1515–1521.
  • Wojcik K, Vogel M, Voigt E, et al. Antiviral therapy for hepatitis C virus recurrence after liver transplantation in HIV-infected patients: outcome in the Bonn cohort. AIDS. 2007;21:1363–1365.
  • Vogel M, Voigt E, Michaelis HC, et al. Management of drug-to-drug interactions between cyclosporine A and the protease inhibitor lopinavir/ritonavir in liver-transplanted HIV infected patients. Liver Transplant. 2004;10:939–944.
  • Jain AK, Venkataramanan R, Shapiro R, et al. The inter-action between antiretroviral agents and tracolimus in liver and kidney transplantation. Liver Transplant. 2002;8:841–845.
  • Bruno R, Sacchi P, Puoti M, et al. Natural history of compen-sated viral cirrhosis in a cohort of patients with HIV-infection. J Acquir Immune Syndr. 2007;46:297–303.
  • Marcellin P, Heathcote EJ, Buti M, et al. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. New Engl J Med. 2008;359:2442–2455.
  • Rockstroh JK, Bahgani S, Benhamou Y, et al., EACS Exec-utive Committee. European AIDS Clinical Society (EACS) for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV infected adults. HIV Med. 2008;9:82–88.
  • Manns MP, Foster GR, Rockstroh JK, et al. The way forward in HCV treatment - finding the right path. Nature Rev Drug Discov. 2007;6:991–1000.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.